fda compounding restrictions bpc-157 advisory committee votes to add popular peptide to drug list fda restrictions bpc-157 compounding The

fda restrictions bpc 157 compounding The internet says is banned the says something more nuanced. Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest

SKU: 5853781439 · From www.paramparam.eu